Overlooked Shortcomings of Observational Studies of Interventions in Coronavirus Disease 2019: An Illustrated Review for the Clinician.
Imad M TleyjehTarek KashourJay MandrekarDiana B PetittiPublished in: Open forum infectious diseases (2021)
The rapid spread of severe acute respiratory syndrome coronavirus 2 infection across the globe triggered an unprecedented increase in research activities that resulted in an astronomical publication output of observational studies. However, most studies failed to apply fully the necessary methodological techniques that systematically deal with different biases and confounding, which not only limits their scientific merit but may result in harm through misleading information. In this article, we address a few important biases that can seriously threaten the validity of observational studies of coronavirus disease 2019 (COVID-19). We focus on treatment selection bias due to patients' preference on goals of care, medical futility and disability bias, survivor bias, competing risks, and the misuse of propensity score analysis. We attempt to raise awareness and to help readers assess shortcomings of observational studies of interventions in COVID-19.
Keyphrases
- coronavirus disease
- respiratory syndrome coronavirus
- sars cov
- healthcare
- end stage renal disease
- physical activity
- newly diagnosed
- ejection fraction
- multiple sclerosis
- chronic kidney disease
- palliative care
- chronic pain
- peritoneal dialysis
- prognostic factors
- quality improvement
- pain management
- health insurance
- global health